Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by Smokey1958on Jan 11, 2022 10:30pm
442 Views
Post# 34306558

Update Today Was Significant

Update Today Was Significant

The update on the clinical trials proposal that Cote first posted today has all sorts of changes and thus information that clearly represents a significant shift in the status of the trials. 

First of all there is the address ...and the website for the site of the clinical trials:

https://www.covidclinic.org/modesto/?utm_source=google&utm_medium=web&utm_campaign=gmb&utm_term=modesto

Then there's the Principal Investigator - Dr. Abinante ...and his now infamous tweet from December 21, 2021

"So proud that I was able to help with this trial...very exciting!" Which trial???

How possible is that across all of the US, with a relatively small number of covid test device submissions in clinical trial, that there would be two trials taking place over the exact same time period at exactly the same site with exactly the same Principal investigator. Impossible, I suppose not. Highly unlikely, absolutely.

Actual Study Start Date - December 6, 2021
Estimated Primary Completion Date - December 31, 2021 ....sound familiar?

Two weeks for submission and an FDA EUA ...this week or next?


Covid infections are increasing exponentially across the globe and in some jurisdictions so have hospitalizations. The world can't make rapid antigen tests fast enough.

Should (when) the FDA EUA (be) is issued I hope Rob can turn on the manufacturing switch the day after.




 

<< Previous
Bullboard Posts
Next >>